Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -654.00K | -709.00K | -402.00K | -386.00K | -677.00K |
| Total Depreciation and Amortization | 24.00K | 24.00K | 23.00K | 22.00K | 21.00K |
| Total Amortization of Deferred Charges | 22.00K | 18.00K | 32.00K | 33.00K | 32.00K |
| Total Other Non-Cash Items | 66.00K | 28.00K | 13.00K | -175.00K | 169.00K |
| Change in Net Operating Assets | 69.00K | 425.00K | 234.00K | 170.00K | -18.00K |
| Cash from Operations | -473.00K | -214.00K | -100.00K | -336.00K | -473.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 187.00K | 200.00K | -- | -- | -- |
| Total Debt Repaid | -83.00K | -139.00K | -46.00K | -45.00K | -154.00K |
| Issuance of Common Stock | 300.00K | -- | -- | 241.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.00K | -17.00K | -- | -- | -- |
| Cash from Financing | 392.00K | 44.00K | -46.00K | 196.00K | -154.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.00K | -170.00K | -146.00K | -140.00K | -627.00K |
